Loading...
XNAS:WINT
Windtree Therapeutics shares are trading higher after announcing a $60 million investment deal to launch a BNB crypto treasury strategy, becoming the first NASDAQ-listed company to offer direct exposure to the BNB token.
Windtree Therapeutics shares are trading higher after the company announced the issuance of a U.S. patent for istaroxime, aimed at treating acute heart failure, providing protection until 2039.
Windtree Therapeutics shares are trading lower after the company disclosed significant uncertainties and risks related to the tech transfer and manufacturing process of PHEXXI, Evofem's hormone-free contraceptive.